Keyword: Drug and Chemical Associated Technologies Association (DCAT)

News

GSK and Regeneron Back UK Biobank Project

29.03.2017 - UK drugmaker GlaxoSmithKline (GSK) and US biotech Regeneron Pharmaceuticals are investing in a gene sequencing project that uses anonymous patient data held by the UK Biobank. The...

News

MedImmune and Sanofi Pasteur in LRTI Drug Pact

29.03.2017 - AstraZeneca’s biologics R&D arm MedImmune and Sanofi’s vaccines division Sanofi Pasteur have agreed to develop and jointly commercialize the monoclonal antibody MEDI8897 for the...

News

US Court Reopens 5,000 Fosamax Lawsuits

29.03.2017 - The US Third Circuit Court of Appeals in Philadelphia, Pennsylvania, has ruled that 5,000 lawsuits brought by patients taking Merck & Co.’s osteoporosis drug Fosamax (alendronate)...

News

Trump Chooses Gottlieb to Head FDA

14.03.2017 - US President Donald Trump has chosen Scott Gottlieb to head the Food and Drug Administration. The 44-year-old former physician, who served as deputy FDA commissioner of medical and...

News

Concordia and Actavis UK Accused of Overpricing

09.03.2017 - The UK’s Competition and Markets Authority (CMA) has accused Concordia and Actavis UK of breaking competition law by agreeing to delay competition and keeping the price of...

News

UK Rejects Keytruda as First Lung Cancer Option

06.03.2017 - Britain's health agency National Institute for Health and Care Excellence (NICE), which has responsibility for assessing the cost-effectiveness of medical treatments, has decided...

News

FDA Accepts Merck-Pfizer Biologics Application

01.03.2017 - In the course of only a week, the US Food and Drug Administration FDA) has accepted the second Biologics License Application (BLA) for priority review. In the latest case, the...

News

Pfizer Appeals UK Fine Over NHS Hike

20.02.2017 - US drugs giant Pfizer has challenged the record £84 million fine imposed by the UK’s Competition and Markets Authority (CMA) for a supply scheme that resulted in a 2,600% price...